Emergent BioSolutions Inc (EBS)

103.65 +2.02  +1.99% NYSE Sep 28, 16:58 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/06/2020 17:00 EST Misc Emergent BioSolutions Inc Third Quarter Earnings Conference Call for 2020
11/06/2020 Earnings Emergent BioSolutions Inc Third Quarter Earnings for 2020 Release
07/30/2020 17:00 EDT Misc Emergent BioSolutions Inc Second Quarter Earnings Conference Call for 2020
07/30/2020 Earnings Emergent BioSolutions Inc Second Quarter Earnings Result for 2020
05/21/2020 09:00 EDT Misc Emergent BioSolutions Inc Annual General Meeting for 2019
04/30/2020 17:00 EDT Misc Emergent BioSolutions Inc First Quarter Earnings Conference Call for 2020
04/30/2020 Earnings Emergent BioSolutions Inc First Quarter Earnings Result for 2020
02/25/2020 Misc Emergent BioSolutions Inc Annual Report for 2019
02/20/2020 17:00 EST Misc Emergent BioSolutions Inc Fourth Quarter Earnings Conference Call for 2019
02/20/2020 Earnings Emergent BioSolutions Inc Fourth Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.emergentbiosolutions.com
  • Investor Relations URL: http://investors.emergentbiosolutions.com/phoenix.zhtml?c=202582&p=irol-IRHome
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: Nov. 06, 2020
  • Last Earnings Release: Jul. 30, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.

Top Fund Holders

Symbol Name Weighting
SBIO ALPS Medical Breakthroughs ETF 3.83%
GERM ETFMG Treatments Testing and Adv ETF 3.70%
FFTY Innovator IBD® 50 ETF 2.97%
BDFUX Baron Discovery R6 2.57%
JCCIX JHancock Small Cap Core I 1.90%
HSVRX Harbor Small Cap Value Admin 1.89%
CSCCX Calvert Small-Cap C 1.88%
NBGAX Neuberger Berman Genesis Adv 1.65%
FSSRX Franklin Small Cap Growth R 1.32%
VTWG Vanguard Russell 2000 Growth ETF 0.52%
IWO iShares Russell 2000 Growth ETF 0.46%
VTWO Vanguard Russell 2000 ETF 0.27%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.